SCHEMBL3246291

SCHEMBL3246291

CN(C)c1ccc(C=CC23OCCN2c2ccc(S(C)(=O)=O)cc2C3(C)C)cc1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ GAA P10253 2/20 0.33
▸ PKM P14618 1/20 0.33
▸ MAPT P10636 4/20 0.32
▸ POLB P06746 1/20 0.32
▸ BCHE P06276 1/20 0.32
▸ MAOB P27338 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.31
▸ PTGS1 P23219 1/20 0.31
▸ APP P05067 2/20 0.31
▸ SLC6A9 P48067 2/20 0.31
▸ ALDH1A1 P00352 1/20 0.30
▸ LMNA P02545 1/20 0.30
▸ SMN1; SMN2 Q16637 1/20 0.30
▸ NPC1 O15118 1/20 0.30
▸ RAB9A P51151 1/20 0.30
▸ L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3254720 1.00 MEN1 (0.39) MEN1KMT2AGAAPKMMAPT
SCHEMBL3246665 0.94 MEN1 (0.37) MEN1KMT2AGAAPKMMAPT
SCHEMBL3257744 0.94 MEN1 (0.37) MEN1KMT2AGAAPKMMAPT
SCHEMBL12311094 0.94 MEN1 (0.37) MEN1KMT2AGAAPKMMAPT
SCHEMBL13963053 0.94 MEN1 (0.38) MEN1KMT2AGAAPKMMAPT
SCHEMBL3254512 0.90 APP (0.33) MEN1KMT2AGAAPKMMAPT
SCHEMBL3254508 0.90 APP (0.33) MEN1KMT2AGAAPKMMAPT
SCHEMBL3254109 0.90 APP (0.33) MEN1KMT2AGAAPKMMAPT
SCHEMBL13963410 0.88 GAA (0.33) GAAPKMMAPTPOLBBCHE
SCHEMBL14922403 0.88 APP (0.35) MEN1KMT2AGAAMAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1747774-B1 Use of a composition comprising a colouring agent of the styrylic or imino type for dyeing keratinuous fibres OREAL (FR) 2010-05-05 — — EP claimed
US-7585332-B2 Composition containing a styryl or imine type dye and a thiol compound, hair coloring process and device L'OREAL S.A. (FR) 2009-09-08 — — US claimed
US-7399319-B2 Dyeing composition comprising a dye chosen from styryl and imine dyes and methods for dyeing keratin fibers L'OREAL S.A. (FR) 2008-07-15 — — US claimed
US-20070174977-A1 Dyeing composition comprising a dye chosen from styryl and imine dyes and methods for dyeing keratin fibers L'OREAL S.A. (FR) 2007-08-02 — — US claimed
EP-1747774-A1 Use of a composition comprising a colouring agent of the styrylic or imino type for dyeing keratinuous fibres L'Oréal (FR) 2007-01-31 — — EP claimed
WO-2010128214-A1 TREATMENT OF COLORED FIBERS BY STYRYL OR IMINE COMPOUNDS IN THE PRESENCE OF ORGANIC OR INORGANIC ACIDS AND ZINC SALTS L´OREAL (FR) 2010-11-11 — — WO disclosed
EP-2083923-B1 COMPOSITION COMPRISING A DYE OF STYRYL OR IMINE TYPE AND A THIOL COMPOUND, DYEING PROCESS AND DEVICE OREAL (FR) 2010-05-05 — — EP disclosed
EP-1747774-B1 Use of a composition comprising a colouring agent of the styrylic or imino type for dyeing keratinuous fibres OREAL (FR) 2010-05-05 — — EP disclosed
US-7585332-B2 Composition containing a styryl or imine type dye and a thiol compound, hair coloring process and device L'OREAL S.A. (FR) 2009-09-08 — — US disclosed
US-7585332-B2 Composition containing a styryl or imine type dye and a thiol compound, hair coloring process and device L'OREAL S.A. (FR) 2009-09-08 — — US disclosed
EP-2083790-A2 DYEING PROCESS USING A DYE OF STYRYL OR IMINE TYPE IN COMBINATION WITH A WEAK ACID AND DEVICE FOR IMPLEMENTING THE PROCESS L'Oreal (FR) 2009-08-05 — — EP disclosed
EP-2083923-A2 COMPOSITION COMPRISING A DYE OF STYRYL OR IMINE TYPE AND A THIOL COMPOUND, DYEING PROCESS AND DEVICE L'Oreal (FR) 2009-08-05 — — EP disclosed
US-7527654-B2 Dyeing process using a dye of styryl or imine type in combination with a weak acid, and device for implementing the process L'OREAL S.A. (FR) 2009-05-05 — — US disclosed
US-20090019645-A1 UNKNOWN L'OREAL S.A. (FR) 2009-01-22 — — US disclosed
US-20080189878-A1 Dyeing process using a dye of styryl or imine type in combination with a weak acid, and device for implementing the process L'OREAL S.A. (FR) 2008-08-14 — — US disclosed
US-7399319-B2 Dyeing composition comprising a dye chosen from styryl and imine dyes and methods for dyeing keratin fibers L'OREAL S.A. (FR) 2008-07-15 — — US disclosed
WO-2008043967-A2 DYEING PROCESS USING A DYE OF STYRYL OR IMINE TYPE IN COMBINATION WITH A WEAK ACID AND DEVICE FOR IMPLEMENTING THE PROCESS L'OREAL (FR) 2008-04-17 — — WO disclosed
WO-2008043968-A2 COMPOSITION COMPRISING A DYE OF STYRYL OR IMINE TYPE AND A THIOL COMPOUND, DYEING PROCESS AND DEVICE L'OREAL (FR) 2008-04-17 — — WO disclosed
US-20070174977-A1 Dyeing composition comprising a dye chosen from styryl and imine dyes and methods for dyeing keratin fibers L'OREAL S.A. (FR) 2007-08-02 — — US disclosed
EP-1747774-A1 Use of a composition comprising a colouring agent of the styrylic or imino type for dyeing keratinuous fibres L'Oréal (FR) 2007-01-31 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090019645-A1 UNKNOWN KRT18, SQOR, MT-ND5 MEN1 3959/4885KMT2A 1588/4885GAA 4757/4885
US-20080189878-A1 Dyeing process using a dye of styryl or imine type in combination with a weak acid, and device for implementing the process KRT18, INHA, IK MEN1 2999/4885KMT2A 809/4885GAA 4420/4885
US-20070174977-A1 Dyeing composition comprising a dye chosen from styryl and imine dyes and methods for dyeing keratin fibers KRT18, INHA, IK MEN1 3368/4885KMT2A 1891/4885GAA 3846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback